Literaturverzeichnis

Albert U-S, Schulz K-D. Ökonomische und strukturelle Aspekte der Brustkrebsfrüherkennung. In: Schulz K-D, Albert U-S (Hrsg.). Stufe-3-Leitlinie Brustkrebsfrüherkennung in Deutschland. München, Wien, New York: Zuckschwerdt Verlag; 2003: 161.

Chen AM, Haffty BG, Lee CH. Local recurrence of breast cancer after breast conservation therapy in patients by means of stereotactic core-needle biopsy. Radiology 2002; 225: 707-712.

Chiarelli A, Doyle G, Kan L, Mah Z, Smith N, Bancej C. Report from the Evaluation Indicators Working Group: Guidelines for Monitoring Breast Screening Program Performance. Health Canada. Minister of Public Works and Government Services. 2002.

Collins LC, Conolly JL, Page DL, Goulart RA, Pisano ED, Fajardo LL, Berg WA, Caudry DJ, McNeil BJ, Schnitt SJ. Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial. Am J Surg Pathol 2004; 28: 126-131.

Diaz LK, Wiley EL, Venta LA. Are malignant cells displaced by large-gauge needle core biopsy of the breast? Am J Roentgenol 1999; 173 (5): 1303-1313.

Groenewoud JH, Pijnappel RM, van den Akker-van Marle ME, Birnie E, Buijs-van der Woude T, Mali WP, de Koning HJ, Buskens E. Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open breast biopsy. Br J Cancer 2004; 90: 383-392.

Hoorntje LE, Schipper ME, Kaya A, Verkooijen HM, Klinkenbijl JG, Rinkes IH. Tumour cell displacement after 14G breast biopsy. Eur J Surg Oncol 2004; 30 (5): 520-525.

Kassenärztliche Bundesvereinigung. Einführung eines bundesweiten Mammographie-Screening-Programms. Deutsches Ärzteblatt, Beilage 2004; Ausgabe A (4): 1-3.

King TA, Hayes DH, Cederbom GJ, Champaign JL, Smetherman DH, Farr GH, Bolton JS, Fuhrman GM. Biopsy technique has no impact on local recurrence after breast-conserving therapy. Breast J 2001; 7 (1): 19-24.

Kreienberg R, Kopp I, Lorenz W, Budach W, Dunst J, Lebeau A, Lück H-J, v. Minckwitz G, Possinger K, Sauerbrei W, Sauerland S, Souchon R, Thomssen C, Untch M, Volm T, Weis J, Schmitt-Reißer B, Koller M, Heilmann V. Diagnostik, Therapie und Nachsorge des Mammakarzinoms der Frau: Eine nationale S3-Leitlinie. Deutsche Krebsgesellschaft e.V., Informationszentrum für Standards in der Onkologie (ISTO), (Hrsg.). Frankfurt a. M.. 2004. http://www.uni-duesseldorf.de/AWMF/ll/032-045.htm (Recherchedatum: 19.01.2007).

Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L (Hrsg.). European guidelines for quality assurance in breast cancer screening and diagnosis. 4. Luxembourg: European Commission; 2006. http://ec.europa.eu/health/ph_projects/2002/cancer/fp_cancer_2002_ext_guid_01.pdf (Recherchedatum: 07.02.2007).

Rubin E, Mennemeyer S, Desmond RA, Urist MM, Waterbor J, Heslin MJ, Bernreuter WK, Demsey PJ, Pile NS, Rodgers WH. Reducing the Cost of Diagnosis of Breast Carcinoma. Cancer 2001; 91: 324-332.

Rutgers EJT. Position Paper EUSOMA Guidelines: Quality control in the locoregional treatment of breast cancer. Eur J Cancer 2001; 37: 447-453.

Schulz KD, Albert US. Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland. Schulz KD, Albert US, (Hrsg.). München, Wien, New York. Zuckschwerdt Verlag; 2003.

Taxin A, Tartter PI, Zappetti D. Breast cancer diagnosis by fine needle aspiration and excisional biopsy. Recurrence and survival. Acta Cytol 1997; 41 (2): 302-306.

Thurfjell MG, Jansson T, Nordgren H, Bergh J, Lindgren A, Thurfjell E. Local breast cancer recurrence caused by mammographically guided punctures. Acta Radiol 2000; 41 (5): 435-440.

Verkooijen HM on behalf of the COBRA Study Group. Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation. Int J Cancer 2002; 99: 853-859.